Please enable JavaScript to continue using this application.

Compare $ACRV vs $PDSB | Chartloom

Compare

$ACRV vs $PDSB

Acrivon Therapeutics Inc · PDS Biotechnology Corp

ACRV

Acrivon Therapeutics Inc

PDSB

PDS Biotechnology Corp

Compare $ACRV vs $PDSB

Comparing Acrivon Therapeutics Inc and PDS Biotechnology Corp

ACRVAcrivon Therapeutics Inc

PDSBPDS Biotechnology Corp

ACRVAcrivon Therapeutics Inc

Market cap

$82M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-22.4%

52W performance

1.6%

FCF yield

-78.5%

PDSBPDS Biotechnology Corp

Market cap

$77M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

65.6%

52W performance

38.0%

FCF yield

-21.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACRV

PDSB

Detailed metrics comparison

ACRV

Acrivon Therapeutics Inc

PDSB

PDS Biotechnology Corp

Market Cap

ACRV$82M

PDSB$77M

Enterprise Value

ACRV$40M

PDSB$76M

Price

ACRV$1.91

PDSB$1.38

P/E Ratio

ACRVN/A

PDSBN/A

P/S Ratio

ACRV0.00x

PDSB0.00x

EV/Sales

ACRV0.00x

PDSB0.00x

EV/EBITDA

ACRV0.00x

PDSB0.00x

P/B Ratio

ACRV0.98x

PDSB10.76x

P/FCF Ratio

ACRVN/A

PDSBN/A

EV/FCF

ACRV-0.63x

PDSB-4.52x

PEG Ratio

ACRVN/A

PDSBN/A

Forward P/E (NTM)

ACRVN/A

PDSBN/A

Forward P/S (NTM)

ACRVN/A

PDSBN/A

Revenue (TTM)

ACRV$0

PDSB$0

Revenue Growth (YoY)

ACRVN/A

PDSBN/A

Forward Rev Growth

ACRV406.9%

PDSB4816.2%

Gross Margin (TTM)

ACRV0.0%

PDSB0.0%

Operating Margin (TTM)

ACRV0.0%

PDSB0.0%

EBITDA Margin (TTM)

ACRV0.0%

PDSB0.0%

Net Margin (TTM)

ACRV0.0%

PDSB0.0%

FCF Margin (TTM)

ACRVN/A

PDSBN/A

Net Income (TTM)

ACRV$-74M

PDSB$-34M

FCF (TTM)

ACRV$-64M

PDSB$-17M

EPS (TTM)

ACRV-$1.77

PDSB-$0.60

ROE (TTM)

ACRV-7014.0%

PDSB-34603.0%

ROA (TTM)

ACRV-6161.0%

PDSB-13650.0%

ROIC (TTM)

ACRV-7014.0%

PDSB-12371.0%

Cash

ACRV$41M

PDSB$6M

Debt

ACRV$0

PDSB$4M

Net Cash/Debt

ACRV$41M

PDSB$1M

Current Ratio (TTM)

ACRV7.99x

PDSB0.57x

Quick Ratio (TTM)

ACRV7.86x

PDSB0.45x

Debt/Equity (TTM)

ACRV0.00x

PDSB4.07x

Debt/Assets (TTM)

ACRV0.0%

PDSB0.0%

Interest Coverage (TTM)

ACRVN/A

PDSBN/A

Net Debt/EBITDA (TTM)

ACRV0.00x

PDSB0.00x

Beta

ACRV1.95

PDSB1.30

52W Performance

ACRV1.6%

PDSB38.0%

YTD Performance

ACRV-22.4%

PDSB65.6%

% from 52W High

ACRV-46.3%

PDSB-11.0%

% from 52W Low

ACRV50.4%

PDSB607.0%

Asset Turnover (TTM)

ACRV0.00x

PDSB0.00x

FCF Yield (TTM)

ACRV-78.5%

PDSB-21.7%

Earnings Yield (TTM)

ACRV-90.8%

PDSB-43.6%

Dividend Yield (TTM)

ACRVN/A

PDSBN/A

Rule of 40

ACRV0.0

PDSB0.0

EV/GP/RG

ACRVN/A

PDSBN/A

Ticker research

View ACRV research View PDSB research

Metric	ACRV Acrivon Therapeutics Inc	PDSB PDS Biotechnology Corp
Market & Valuation
Market Cap	$82M	$77M
Enterprise Value	$40M	$76M
Price	$1.91	$1.38
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.98x	10.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-4.52x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	406.9%	4816.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-74M	$-34M
FCF (TTM)	$-64M	$-17M
EPS (TTM)	-$1.77	-$0.60
ROE (TTM)	-7014.0%	-34603.0%
ROA (TTM)	-6161.0%	-13650.0%
ROIC (TTM)	-7014.0%	-12371.0%
Financial Health
Cash	$41M	$6M
Debt	$0	$4M
Net Cash/Debt	$41M	$1M
Current Ratio (TTM)	7.99x	0.57x
Quick Ratio (TTM)	7.86x	0.45x
Debt/Equity (TTM)	0.00x	4.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	1.30
52W Performance	1.6%	38.0%
YTD Performance	-22.4%	65.6%
% from 52W High	-46.3%	-11.0%
% from 52W Low	50.4%	607.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-78.5%	-21.7%
Earnings Yield (TTM)	-90.8%	-43.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACRV research	View PDSB research

Valuation

P/S Ratio

ACRV

0.00x

PDSB

0.00x

EV/FCF

PDSB

-4.52x

ACRV

-0.63x

Growth & revenue

Forward Revenue Growth

PDSB

4816.2%

ACRV

406.9%

Profitability & performance

Gross Margin

ACRV

0.0%

PDSB

0.0%

ROE

ACRV

-7014.0%

PDSB

-34603.0%

FCF Yield %

PDSB

-21.7%

ACRV

-78.5%

52-Week Performance

PDSB

38.0%

ACRV

1.6%

Detailed metrics comparison

ACRV

Acrivon Therapeutics Inc

PDSB

PDS Biotechnology Corp

Market Cap

ACRV$82M

PDSB$77M

Enterprise Value

ACRV$40M

PDSB$76M

Price

ACRV$1.91

PDSB$1.38

P/E Ratio

ACRVN/A

PDSBN/A

P/S Ratio

ACRV0.00x

PDSB0.00x

EV/Sales

ACRV0.00x

PDSB0.00x

EV/EBITDA

ACRV0.00x

PDSB0.00x

P/B Ratio

ACRV0.98x

PDSB10.76x

P/FCF Ratio

ACRVN/A

PDSBN/A

EV/FCF

ACRV-0.63x

PDSB-4.52x

PEG Ratio

ACRVN/A

PDSBN/A

Forward P/E (NTM)

ACRVN/A

PDSBN/A

Forward P/S (NTM)

ACRVN/A

PDSBN/A

Revenue (TTM)

ACRV$0

PDSB$0

Revenue Growth (YoY)

ACRVN/A

PDSBN/A

Forward Rev Growth

ACRV406.9%

PDSB4816.2%

Gross Margin (TTM)

ACRV0.0%

PDSB0.0%

Operating Margin (TTM)

ACRV0.0%

PDSB0.0%

EBITDA Margin (TTM)

ACRV0.0%

PDSB0.0%

Net Margin (TTM)

ACRV0.0%

PDSB0.0%

FCF Margin (TTM)

ACRVN/A

PDSBN/A

Net Income (TTM)

ACRV$-74M

PDSB$-34M

FCF (TTM)

ACRV$-64M

PDSB$-17M

EPS (TTM)

ACRV-$1.77

PDSB-$0.60

ROE (TTM)

ACRV-7014.0%

PDSB-34603.0%

ROA (TTM)

ACRV-6161.0%

PDSB-13650.0%

ROIC (TTM)

ACRV-7014.0%

PDSB-12371.0%

Cash

ACRV$41M

PDSB$6M

Debt

ACRV$0

PDSB$4M

Net Cash/Debt

ACRV$41M

PDSB$1M

Current Ratio (TTM)

ACRV7.99x

PDSB0.57x

Quick Ratio (TTM)

ACRV7.86x

PDSB0.45x

Debt/Equity (TTM)

ACRV0.00x

PDSB4.07x

Debt/Assets (TTM)

ACRV0.0%

PDSB0.0%

Interest Coverage (TTM)

ACRVN/A

PDSBN/A

Net Debt/EBITDA (TTM)

ACRV0.00x

PDSB0.00x

Beta

ACRV1.95

PDSB1.30

52W Performance

ACRV1.6%

PDSB38.0%

YTD Performance

ACRV-22.4%

PDSB65.6%

% from 52W High

ACRV-46.3%

PDSB-11.0%

% from 52W Low

ACRV50.4%

PDSB607.0%

Asset Turnover (TTM)

ACRV0.00x

PDSB0.00x

FCF Yield (TTM)

ACRV-78.5%

PDSB-21.7%

Earnings Yield (TTM)

ACRV-90.8%

PDSB-43.6%

Dividend Yield (TTM)

ACRVN/A

PDSBN/A

Rule of 40

ACRV0.0

PDSB0.0

EV/GP/RG

ACRVN/A

PDSBN/A

Ticker research

View ACRV research View PDSB research

Metric	ACRV Acrivon Therapeutics Inc	PDSB PDS Biotechnology Corp
Market & Valuation
Market Cap	$82M	$77M
Enterprise Value	$40M	$76M
Price	$1.91	$1.38
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.98x	10.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-4.52x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	406.9%	4816.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-74M	$-34M
FCF (TTM)	$-64M	$-17M
EPS (TTM)	-$1.77	-$0.60
ROE (TTM)	-7014.0%	-34603.0%
ROA (TTM)	-6161.0%	-13650.0%
ROIC (TTM)	-7014.0%	-12371.0%
Financial Health
Cash	$41M	$6M
Debt	$0	$4M
Net Cash/Debt	$41M	$1M
Current Ratio (TTM)	7.99x	0.57x
Quick Ratio (TTM)	7.86x	0.45x
Debt/Equity (TTM)	0.00x	4.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	1.30
52W Performance	1.6%	38.0%
YTD Performance	-22.4%	65.6%
% from 52W High	-46.3%	-11.0%
% from 52W Low	50.4%	607.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-78.5%	-21.7%
Earnings Yield (TTM)	-90.8%	-43.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACRV research	View PDSB research